Literature DB >> 11805141

Ribozyme-mediated attenuation of survivin expression sensitizes human melanoma cells to cisplatin-induced apoptosis.

Marzia Pennati, Gennaro Colella, Marco Folini, Lorenzo Citti, Maria Grazia Daidone, Nadia Zaffaroni.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11805141      PMCID： PMC150847          DOI： 10.1172/JCI14891

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  9 in total

1.  Analysis of human transcriptomes.

Authors:  V E Velculescu; S L Madden; L Zhang; A E Lash; J Yu; C Rago; A Lal; C J Wang; G A Beaudry; K M Ciriello; B P Cook; M R Dufault; A T Ferguson; Y Gao; T C He; H Hermeking; S K Hiraldo; P M Hwang; M A Lopez; H F Luderer; B Mathews; J M Petroziello; K Polyak; L Zawel; K W Kinzler
Journal:  Nat Genet       Date:  1999-12       Impact factor: 38.330

2.  Communication: expression of the novel inhibitor of apoptosis survivin in normal and neoplastic skin.

Authors:  C Chiodino; A M Cesinaro; D Ottani; F Fantini; A Giannetti; G P Trentini; C Pincelli
Journal:  J Invest Dermatol       Date:  1999-09       Impact factor: 8.551

Review 3.  The Survivin saga goes in vivo.

Authors:  J C Reed
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

4.  A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma.

Authors:  G Ambrosini; C Adida; D C Altieri
Journal:  Nat Med       Date:  1997-08       Impact factor: 53.440

5.  Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma.

Authors:  D Grossman; J M McNiff; F Li; D C Altieri
Journal:  J Invest Dermatol       Date:  1999-12       Impact factor: 8.551

6.  Expression of survivin and Bcl-2 in the normal human endometrium.

Authors:  R Konno; H Yamakawa; H Utsunomiya; K Ito; S Sato; A Yajima
Journal:  Mol Hum Reprod       Date:  2000-06       Impact factor: 4.025

7.  Cancer gene therapy using a survivin mutant adenovirus.

Authors:  M Mesri; N R Wall; J Li; R W Kim; D C Altieri
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

Review 8.  Survivin apoptosis: an interloper between cell death and cell proliferation in cancer.

Authors:  D C Altieri; P C Marchisio; C Marchisio
Journal:  Lab Invest       Date:  1999-11       Impact factor: 5.662

9.  Inhibition of melanoma tumor growth in vivo by survivin targeting.

Authors:  D Grossman; P J Kim; J S Schechner; D C Altieri
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-09       Impact factor: 11.205
  9 in total
  26 in total

1.  Molecular mechanism of inhibition of survivin transcription by the GC-rich sequence-selective DNA binding antitumor agent, hedamycin: evidence of survivin down-regulation associated with drug sensitivity.

Authors:  Jianguo Wu; Xiang Ling; Dalin Pan; Pasha Apontes; Lei Song; Ping Liang; Dario C Altieri; Terry Beerman; Fengzhi Li
Journal:  J Biol Chem       Date:  2005-01-05       Impact factor: 5.157

2.  Antisense RNA of survivin gene inhibits the proliferation of leukemia cells and sensitizes leukemia cell line to taxol-induced apoptosis.

Authors:  Wenhan Li; Xiaojuan Wang; Ping Lei; Qing Ye; Huifen Zhu; Yue Zhang; Jinfang Shao; Jing Yang; Guanxin Shen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-02

3.  Sanguinarine suppresses prostate tumor growth and inhibits survivin expression.

Authors:  Meng Sun; Wei Lou; Jae Yeon Chun; Daniel S Cho; Nagalakshmi Nadiminty; Christopher P Evans; Jun Chen; Jiao Yue; Qinghua Zhou; Allen C Gao
Journal:  Genes Cancer       Date:  2010-03

4.  Preparation of anti-mouse caspase-12 mRNA hammerhead ribozyme and identification of its activity in vitro.

Authors:  Shan Jiang; Qing Xie; Wei Zhang; Xia-Qiu Zhou; You-Xin Jin
Journal:  World J Gastroenterol       Date:  2005-07-14       Impact factor: 5.742

5.  Inhibition of human lung adenocarcinoma growth using survivint34a by low-dose systematic administration.

Authors:  Yan Shan; Chunting Wang; Li Yang; Li Juan Chen; Hong Xin Deng; Han Shuo Yang; Zhimian Li; Zhiyong Li; Li Pan; Fei Leng; Yuquan Wei
Journal:  J Biosci       Date:  2010-06       Impact factor: 1.826

6.  Differential regulation of survivin expression and apoptosis by vitamin D3 compounds in two isogenic MCF-7 breast cancer cell sublines.

Authors:  Fengzhi Li; Xiang Ling; Huayi Huang; Lisa Brattain; Pasha Apontes; Jianguo Wu; Lise Binderup; Michael G Brattain
Journal:  Oncogene       Date:  2005-02-17       Impact factor: 9.867

7.  Selenium inhibition of survivin expression by preventing Sp1 binding to its promoter.

Authors:  Jae Yeon Chun; Yan Hu; Elaine Pinder; Jianguo Wu; Fengzhi Li; Allen C Gao
Journal:  Mol Cancer Ther       Date:  2007-09       Impact factor: 6.261

8.  Tetra-O-methyl nordihydroguaiaretic acid induces growth arrest and cellular apoptosis by inhibiting Cdc2 and survivin expression.

Authors:  Chih-Chuan Chang; Jonathan D Heller; Jennifer Kuo; Ru Chih C Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-25       Impact factor: 11.205

Review 9.  Chemoprevention of melanoma.

Authors:  Marie-France Demierre; Glenn Merlino
Journal:  Curr Oncol Rep       Date:  2004-09       Impact factor: 5.075

10.  Enhancement of cisplatin sensitivity in Lewis Lung carcinoma by liposome-mediated delivery of a survivin mutant.

Authors:  Dan-Dan Yu; Chun-Ting Wang; Hua-Shan Shi; Zhi-Yong Li; Li Pan; Qing-Zhong Yuan; Fei Leng; Yuan Wen; Xiang Chen; Yu-Quan Wei
Journal:  J Exp Clin Cancer Res       Date:  2010-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.